Novartis posts better-than-expected first-quarter sales, raises full-year guidance
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Novartis posts better-than-expected first-quarter sales, raises full-year guidance
Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year guidance.
General Motors is set to report earnings before the bell. Here's what Wall Street expects
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
General Motors beats Wall Street estimates, reassesses full-year guidance amid auto tariffs
GM beat expectations but is reassessing its 2025 guidance and suspending any additional stock buybacks amid expected cost increases and industry uncertainty.
Coca-Cola tops earnings estimates, keeps full-year outlook as it expects minimal tariff disruption
US Top News and Analysis (RSS)
US Top News and Analysis (RSS)
CNBC
Coke keeps full-year forecast, says it expects tariff disruptions to be 'manageable' after Pepsi cuts earnings outlook
Coke beat first-quarter earnings estimates, and unlike rival Pepsi, maintained its full-year outlook as it expects cost hikes from tariffs to be "manageable."